Focused Wealth Management, Inc - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$9,000
+200.0%
1,520
-33.8%
0.00%
+200.0%
Q4 2018$3,000
-50.0%
2,295
+26.4%
0.00%
-50.0%
Q3 2018$6,000
-79.3%
1,815
-71.6%
0.00%
-80.0%
Q2 2018$29,000
-29.3%
6,395
-48.4%
0.01%
-23.1%
Q1 2018$41,000
+355.6%
12,395
+417.5%
0.01%
+333.3%
Q4 2017$9,000
-93.3%
2,395
-81.7%
0.00%
-93.3%
Q3 2017$135,000
+15.4%
13,065
+8.9%
0.04%
+2.3%
Q2 2017$117,000
+42.7%
11,9950.0%0.04%
+37.5%
Q1 2017$82,000
+28.1%
11,995
+2.8%
0.03%
+18.5%
Q4 2016$64,000
-55.6%
11,665
-38.5%
0.03%
-57.1%
Q3 2016$144,000
+11.6%
18,968
+19.5%
0.06%
+6.8%
Q2 2016$129,000
-40.3%
15,868
-4.4%
0.06%
-50.0%
Q1 2016$216,000
-16.6%
16,593
+28.6%
0.12%
-20.8%
Q4 2015$259,000
+99.2%
12,898
+21.2%
0.15%
+79.5%
Q3 2015$130,000
+85.7%
10,646
+212.6%
0.08%
+93.0%
Q2 2015$70,000
-15.7%
3,406
-12.9%
0.04%
-15.7%
Q1 2015$83,000
+66.0%
3,909
+139.2%
0.05%
+45.7%
Q4 2014$50,000
+525.0%
1,634
+263.1%
0.04%
+483.3%
Q3 2014$8,0004500.01%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,208,210$16,738,232,00018.66%
ProQuest Associates IV LLC 1,962,720$14,877,0004.10%
BVF INC/IL 1,200,000$9,096,0001.71%
Abingworth LLP 197,300$1,494,0001.43%
NEXTHERA CAPITAL LP 305,000$2,312,0001.42%
Cormorant Asset Management, LP 432,990$3,282,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 203,000$1,539,0000.25%
DAFNA Capital Management LLC 40,000$303,0000.21%
Monashee Investment Management LLC 50,000$379,0000.13%
Eventide Asset Management 180,000$1,364,0000.08%
View complete list of IMMUNE DESIGN CORP shareholders